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Abstract
The global shortage of donor organs is a cause for countless fatalities across the world. Although, diseases can be
treated through organ transplantation it can come along with many complications. Not only is there a high demand for
donor organs, there is also the risk of the body’s rejection of the newly implanted organ. Through the method of 3D
printing organs, many lives could be saved as well as reducing the need for donor organs. Finding materials to create a
suitable scaffold is the focus of many experiments. Materials that are used in organ printing are made from soft materials,
therefore, suspended hydrogel techniques are utilized for printing organs and for creating vascularization systems in the
printed organs. The vascularization level of 3D printed organs is the most complicated because of its vast and detailed
preciseness. Detailed magnetic resonance imaging is taken to generate the 3D image of the structure and consequently
print the image layer by layer as opposed to the older method of manually applying cells onto scaffolds. While many
research teams have made progress with 3D organ printing, complex organs such as the heart and kidney are currently
undergoing research to be implemented into clinical settings.
Introduction
Transplanting new organs is a way of trying to deal with life
threatening diseases. Instead of the chronic maintenance of diseased organs medical professionals would be able to replace
them, thus curing the condition. One leading major health crisis is the shortage of organs available for transplants. Although
medicine’s advancements help people live longer, organs tend
to fail more often as a result of longer lifespans. For instance,
in the United States, a name is added to the Transplant List
on an average of every ten minutes. Additionally, the number
of patients needing organs have doubled while the amount of
transplant procedures has barely increased (OPTN, 2016). 3D
organ printing technology is a promising step to help solve the
organ transplantation crisis.
The field of regenerative medicine deals with replacing, engineering, or regenerating human cells, tissues, or organs in order
to help achieve normal function. Regenerative medicine is not
a new field; Alexis Carrel, a Nobel Prize winner, writes in his
book, “The Culture of Organs” (Carrel, Lindbergh, 1938) about
technologies that are still used today for blood vessel grafting.
Thomas Boland, self-described as the “grandfather of bioprinting,” took an old Lexmark computer, emptied the ink cartridge
and filled it with collagen instead. He then glued a thin, black
silicon sheet onto blank paper and inserted it into the printer.
He opened a Word document on his PC, typed his initials, and
hit print.The paper came out with “TB” clearly presented in offwhite proteins. By 2000, Boland and his team had reconfigured
a Hewlett-Packard DeskJet 550C to print with E. coli bacteria.
Then they expanded to larger mammalian cells obtained from
Chinese hamsters and lab rats. Once printed, 90 percent of the
cells remained viable, which meant the product was useful, not
only art. Boland introduced 3D printing for cellular construct
when he patented the process for using the ink-jet printer for
printing cells. Boland’s process used a system where cells were
deposited into 3D matrices placed on a substrate. Instead of
using ink, 3D printers use cells in a cartridge where the cells are

66

being layered in order to create a three-dimensional structure
that can lead to functional organs and tissues (Wilson, Boland,
2003). This paper will review the current progress in organ
printing technology with its promises and challenges and evaluate whether functional organs can be produced.

Methods
The information in this paper was obtained by the analysis of
scientific articles and research papers obtained from the Touro
College Online Library, specifically, the Health Science related databases such as Pubmed, Proquest Medical Library, and
EBSCO multisearch.Additionally, websites like NIH.gov,Webmd.
com, Mayoclinic.com and OPTN.com were used to gain general
knowledge and information about the subject. Keywords such
as “3D organ printing” and “regenerative medicine” were used
to search for scientific articles.

Discussion:The Bladder
At first, researchers were pipetting cells into petri dishes by
hand without the use of 3D printers. To do so, researchers
would seed the cells from the petri dishes onto artificial scaffolds; a suitable base for the organs. The scaffolds were made
from biodegradable polymers or collagen which provided a
temporary matrix for the cells to cling to until they were able
to stand on their own. Dr. Anthony Atala, the lead researcher
at Wake Forest Institute for Regenerative Medicine, implanted
the first lab grown bladder organs into seven patients at Boston
Children’s Hospital between 1999 and 2001 (Atala et. al., 2006).
There are a variety of injuries that can lead to damage or loss
of the bladder, requiring eventual replacement or repair of the
organ. Children with congenital anomalies such as: bladder exstrophy, myelomeningocele, or posterior urethral valves, can
develop high-pressure and hypertonic low compliant bladders.
Often times, these patients require cystoplasty when drug
treatment fails. Gastrointestinal segments are frequently used
as donor tissues for cystoplasty. However, when such tissues
are incorporated into the urinary tract, several complications
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can ensue; such as metabolic disturbances, urolithiasis, increased
mucous production, and malignant disease (Emedicine, 2016).
Atala, along with his research team, explored an alternative approach using autologous engineered bladder tissue for reconstruction. Seven patients with myelomeningocele, aged 4-19 years
old, with poorly compliant bladders were identified as candidates
for cystoplasty. Urethral and muscle cells from the patients
were grown in a culture, and seeded on a biodegradable bladder
shaped scaffold made of collagen, or a composite of collagen and
polyglycolic acid. About seven weeks after biopsy, the autologous
engineered bladder constructs were used for reconstruction and
implanted into patients. Tests such as serial urodynamics, cytograms, ultrasounds, bladder biopsies and serum analyses were
performed. The bowel function of the patients returned to normal promptly after surgery with no metabolic consequences and
renal function was preserved (Atala et. al., 2006).
Researchers soon adopted 3-D printers to make scaffolds
more precisely because manually placing the cells onto scaffold
remained a time-consuming and arduous process. Engineered
bladders were made possible because they can be made with
just two cell types however, an organ such as a kidney consists
of thirty cell types.When attempting to engineer more complex
tissues, there is no way to manually place different cell types into
different locations that can replicate the native tissue structures.
Manual placement is not the optimal method for delivering cells
(Murphy, Atala, 2014).

The Heart
The human heart is a complex biological machine. It pumps
blood to all parts of the body, begins to beat three weeks after
conception and does not stop until the day of death. It is remarkable how the heart can last that long and function with the
same redundancy and efficacy. The heart operates for billions of
cycles, it is chemically powered and electrically synchronized.
The heart is composed of over a hundred billion cells including
cardiomyocytes, conduction system, fibroblasts, endothelial cells,
smooth muscle cells and neurons. The main reason researchers
are trying to 3D print the heart is because the heart is unable to
regenerate itself and for this reason heart disease is the leading
cause of death in first world countries (Mayo Clinic, 2016).
A heart transplant is a lifesaving procedure which removes a
damaged or diseased heart and replaces it with a new one.
Heart failures come as a result of different conditions such as
coronary heart disease, damaged heart muscle or valves, congenital heart defects, or viral infections of the heart. Once the
human heart is damaged, there is only a limited amount of regeneration that can occur and may require a heart transplant.
A heart transplant comes with many risks and complications

such as infection or the recipient’s body attempting to reject
the newly placed heart. To prevent rejection, the patients must
immediately be given immunosuppressants as a lifelong treatment (Mayo clinic, 2016). There are currently 4,138 candidates
who are on the UNOS list for a heart transplant (OPTN, 2016).
The high number of candidates results in an agonizing wait for
a new heart which usually does not have a positive ending. This
long waiting list can be reduced through the possibility of 3D
printing of the human heart.
The hierarchical structure and function in the heart has levels
that scales from the nanometer level up to the macroscopic
level. Every heart beat is powered by molecular motors, the
actin and myosin, which are only a few nanometers in size and
generate pico newtons amount of force. The actin and myosin
are built into larger structures called the sarcomeres, the contractile unit of a muscle cell. Then, these are built into myofibrils
which form tissue and surrounds the ventricles of the heart. At
this present day, technology is unable to engineer something
this complex starting from the nanometer scale and up. Yet, scientists are able to figure out where they are able to interface
with the system, by providing information into the biology that
can guide the living system to do the work of producing the
components of the microstructures. Once the cells are formed,
they themselves manufacture the microstructures necessary
and the 3D bioprinting scaffolds, the suitable base, are used to
build larger structures up to the size of a whole organ.
The embryo is a perfect example of biological manufacturing, it
starts off with one cell and those cells divide and build an extracellular matrix around themselves until there is a full functioning organism. The extracellular matrix is a nanofiber network of
protein and other molecules. It mechanically integrates cells into
tissues, acts as an insoluble signaling network and functions as a
scaffold that fills the space between the cells and tissues.This matrix acts as information because it provides cells with instructive
cues on how to organize and form tissue. It signals between the
cells using physics, chemistry and mechanics and is integral to
tissue formation and function (Rozario, Desimone, 2010). A technique called Bottom Up Engineering of the Extracellular Matrix
(ECM) was an attempt to build the ECM in the same way cells do;
from single molecules into a complex 3D fiber with tissue specific
structure and function according to the organ that is being engineered. This technique thereby accelerates the system of tissue
formation (Szymanski et. al., 2014).
The idea of using the extracellular matrix is utilized in the following technique for 3D bioprinting organs and other structures. Soft materials such as collagen and fibrin are difficult for
scientists to work with because they collapse under their own
weight and do not have the mechanical strength to be printed
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in air. To overcome this problem, a gel in gel technique dubbed
Freeform reversible embedding of suspended hydrogels is used.
This approach involves soft materials such as fibrin, collagen
and the polysaccharide alginate. The materials are inside a thick
slurry of gelatin microparticles and water in a petri dish. The
semiliquid mixture of gelatin microparticles is able to flow
around the printing needle as it operates. At the same time, the
soft biomaterials being released are firmly implanted during the
layer by layer printing technique. Once the printing of the scaffolds is completed, the dish is warmed up to 37 degrees Celsius
thereby removing the gelatin and revealing the scaffold replica
of an organ or tissue (Hinton et. al., 2015, Figure 1).

Figure 2 (Hinton et. al., 2015)

Figure 1 (Hinton et. al., 2015)
Freeform reversible embedding of suspended hydrogels
technique
One application of this technique is using magnetic resonance imaging (MRI) to print patient specific scaffolds to engineer tissues.
Through magnetic imaging the right coronary arterial tree is 3D
printed. The right coronary artery along with the left coronary
artery supplies blood to the heart. The right coronary artery is
specifically responsible to supply blood to the right atrium, right
ventricle, bottom portion of the left ventricle and the back of
the septum. Additionally, the coronary arteries become blocked
during a heart attack. The 3D printed artery was made of ECM
materials such as fibrin, hyaluronic acid and alginate with solid
walls and an open lumen. On a makerbot 3D printer the artery
took about one hour to print which is the timeframe within the
viability of cells. The wall thickness, lumen diameter and density
can be tailored based on patient anatomy. To evaluate whether
the 3D printed arterial tree was manifold it was set up in a custom made 3D printed perfusion fixture. A solution of CaCl₂ and
0.1% black food coloring was injected into the root of the tree.
Perfusion was successful and captured on camera. The printed
coronary artery has not been used for transplants such as a coronary artery bypass, yet this technique is a step up from the current printing of just straight tubes. This technique creates more
complex architecture like the real coronary artery tree that can
hold a better potential graft (Hinton et. al., 2015, Figure 2).

68

(D) A model of a section of a human right coronary arterial tree
from 3D MRI is processed at full scale into machine code for FRESH
printing. (E) An example of the arterial tree printed in alginate (black)
and embedded in the gelatin slurry support bath. (F) A section of
the arterial trees printed in fluorescent alginate (green) and imaged
in 3D to show the hollow lumen and multiple bifurcations. (G) A
zoomed-in view of the arterial tree shows the defined vessel wall that
is <1 mm thick and the well-formed lumen. (H) A dark-field image of
the arterial tree mounted in a perfusion fixture to position a syringe
in the root of the tree. (I) A time-lapse image of black dye perfused
through the arterial tree false-colored at time points of 0 to 6 s to
show flow through the lumen and not through the vessel wall. Scale
bars, 4 mm (B), 10 mm (E), 2.5 mm (F), 1 mm (G), and 2.5 mm (H
and I). (Hinton et. al., 2015).
Another application of the Freeform reversible embedding of
suspended hydrogels technique is used to build the embryonic
heart. The 3D model of the embryonic chick heart was generated from 3D optical imaging data of a fluorescently labeled
5-day-old heart.The embryonic stage is the time when the heart
muscle forms. It is the only time where the human body has the
potential to form new heart muscle. In order to accurately 3D
print an organ, there needs to be accurate data input to the
system. The first step is the 3D imaging of the embryonic heart
to identify the ECM macrostructure and microstructure associated with myogenesis and vascularization. 3D imaging goes
through the embryonic heart and images the entire heart, ventricles, and trabeculated tissue together with all the exquisite
details. A 3D computer model of the trabeculated embryonic
heart is generated based on confocal imaging of cells and the
extracellular matrix. Then, based on the computer model the
3D heart is printed and compared with the computer generated image (Hinton et. al., 2015, Figure 3).

3D Organ Printing

One step further in 3D cardiac printing is the ability to print
cardiac cells called organoids. This research called “Body on
a Chip” is currently ongoing at Wake Forest Baptist Medical
Center. The research converted human skin cells into a network of functioning heart cells, and also fused them with lab
grown liver cells using a 3D printer. The heart organoid is able
to beat because it contains specialized cardiac cells and the cells
receive correct environmental cues such as keeping them at

Figure 3
Printed embryonic heart scaffolds with complex internal
and external architectures based on 3D imaging data from
whole organs
the same temperature as the human body. The organoid heart
cells are made by genetically modifying adult human skin cells
into induced pluripotent stem cells. Then, these cells are reprogrammed to produce the organoids which have a diameter of
0.25 millimeters. The organoids grow and form balls which then
are 3D printed into different forms and sizes. These cells will
create tiny organ-like structures that mimic the function of the
real organ. The organ structures are then placed on a chip to
provide for an online monitoring. The ultimate goal is to create
mini organs to test them with different biological and chemical

agents and the effectiveness of various treatments against diseases (Wakehealth.edu 2016, Figure 4).

The Kidney
In addition to the great need of heart transplants there is even
a greater number of patients waiting for a kidney transplant.
Currently, there are over a hundred thousand people anxiously
waiting for a lifesaving kidney (OPTN, 2016). The kidneys are
responsible for removing excess fluid and waste from the blood.
When the kidneys lose their filtering ability, there is a dangerously high level of fluid and waste accumulating in the body. This
condition is known as kidney failure or end stage kidney disease.
A kidney transplant procedure is often the best way to treat
a kidney failure. Only one kidney is necessary to replace two
failed kidneys, thus making a living donor kidney transplantation
possible (Kidney.org, 2014).
A kidney transplant can pose risks to both the donor and the
recipient. There can be possible surgical complications such as
pain, infection, blood loss, blood clots, allergic reactions to anesthesia, pneumonia, injury to surrounding tissue and organs, or
even death. There are also long term risks for donating a kidney
such as hypertension, large amounts of protein in the urine, hernia, organ impairment or failure that can lead to the need for dialysis or transplantation and can even cause death. Additionally,
there is the problem of the recipient’s body rejecting the kidney
as a foreign invader. Just as in a heart transplant, the patient will
need to remain on immunosuppressants every day to prevent
rejection of the new kidney. These anti-rejection medications
have a large number of possible side effects because the body’s
immune system is suppressed (kidney.org, 2014).
Dr. Anthony Atala demonstrated an early stage experiment that
could solve the kidney organ donor problem. The experiment
uses a 3D printer that contains live cells and kidney shaped structure of collagen to output a transplantable kidney. A blueprint is
created through a CT scan that goes layer by layer using computerized morphometric imaging analysis and 3D reconstruction
which leads to actually imaging the kidneys. The image can even
do a full 360-degree rotation to analyze the kidney in its full volumetric characteristics.This information is then taken and scanned
into a printing computerized form. The printer is then guided by
the computer imaging and drips the cells layer by layer over the
scaffold causing the inert mold to come to life. Overtime, the
millions of cells begin to communicate and function as one organ.
It took the research team about seven hours to print the 3D
kidney structure (Murphy, Atala, 2014, Figure 5, Xu et al., 2013).

Vascularization
Figure 4 (Wakehealth.edu
3D printed beating, cardiac cells called “organoids)

The kidney represents a challenge more than other organs due
to the kidney’s detailed, tiny structures that allow the organ
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to perform its sophisticated filtration job by removing waste
chemicals from blood and turning the waste into urine. The
function of removing waste is processed by roughly one million
nephrons which are tiny vessels made up of even smaller urine
collecting structures called tubules.The kidneys are also responsible to measure chemicals such as sodium and potassium that
are then released back into the bloodstream in healthy dosag-

Figure 5 (Murphy, Atala, 2014) (TED.com 2011)
Dr. Atala holding his printed kidney during a TED talk
called “On Printing a Human Kidney,” in March 2011.
es. The kidney’s complex vascular structure especially poses a
challenge. The vascular tree of the kidney can come down to
the size of a capillary about eight microns in diameter. Due to
the kidney’s complexity, it has not been printed for transplant
in humans at this present time, however researchers are avidly
looking for ways to make it a reality and help people suffering
from dialysis treatments while being on a multiple year waiting
list for a kidney (Murphy, Atala, 2014).
For a transplant tissue to thrive, a complex level of vascularization must be achieved. To some extent, capillaries can branch
out from already existing blood vessels and into transplanted
tissue on their own. Researchers have seen signs of spontaneous vascularization in small areas of engineered tissue such as
in healed rat bone defects around three millimeters in diameter
(Fielding, Bose, 2013). Rather than letting blood vessels spontaneously branch off and expand to engineered tissue, researchers
are crafting templates for more orderly vascular growth. The
idea is to create hierarchical microvascular networks that will
guide the endothelial cells that line blood vessels to form tubes
along predetermined courses. However, capillaries are small,
measuring just a few microns in diameter. Therefore, even with
high resolution printers, such small vascular structures would
most likely collapse especially when printed into soft, biocompatible gel.
Jennifer Lewis researched the vascularization problem using
a customized, high resolution 3D printer that can form microchannels in biocompatible gels. Lewis’s research group is
able to print hydrogel materials down at the micron length
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scale. The smallest microvascular channel the group was able
to print was about ten microns in diameter. To solve the problem of collapsing channels, she prints them in fugitive ink which
is a substance designed to melt away forming the channels
pattern. The fugitive ink used is called Pluronic 4127, a gel that
is often used in eyeglass lense cleanser and cosmetics. Pluronic
4127 is made up of three parts, the two poles of the molecule
are hydrophilic while the middle segment is hydrophobic. The
ink also liquefies when it is cooled down as opposed to most
materials that solidify when they are cooled down (Wu et.
al.,2011).
Lewis also used Pluronic F127 as the matrix for the printed
channels, but the matrix molecules were modified so that they
polymerize, and thus solidify, in the presence of UV light. This
allows the matrix to become firm before cooling the gel so that
the fugitive ink melts away.Taking advantage of the printer’s finetipped nozzle, the research team printed a capillary network
of fluorescently labeled fugitive ink into the Jello-like matrix.
Through this technique, a way to pattern hydrogels with vascular channels was accomplished (Wu et. al., 2011). The next step
is to take advantage of the self-organizing quality of endothelial
cells in the 3-D–printed constructs, seeding the printed vascular
structures with these blood vessel–lining cells. The self organizing quality is the tendency of the finest capillaries to grow
spontaneously out of larger microvascular structures which is
the work of biology when the cells are given a reasonable environment (Perryn et. al., 2008).
Inspired by some of Lewis’s lab work with “fugitive inks,” Jordan
Miller, at Rice University, created a technique for 3D printing of
vasculature-mimicking channels. Using a simple open-source 3D
printer, Miller and his team constructed a carbohydrate lattice
made from a combination of simple and complex sugars. There is
a major difference between Miller’s experiments and those done
by Jennifer Lewis. Lewis uses machines that are very high-end
and have incredible precision, but they are not easily duplicated
by others. Miller saw potential in a cheaper printer called the
Frostruder, a printer originally used to extrude sugar frosting for
printing fancy designs onto edible treats. Miller adapted a printer
to incorporate elements of the Frostruder printer’s design and
was soon able to print dissolvable lattices of carbohydrate filaments (Miller et. al., 2012). The experiment used a process called
“3-D sacrificial molding” that is similar to the lost-wax method
used by sculptors. His printer deposits filaments of carbohydrate
on top of each other in sequence so they are self-supporting.
Then the entire lattice structure is covered in a protective layer
of a biodegradable polymer. After pouring and cross linking a cellfilled gel over the carbohydrate lattice, the lattice is dissolved with
an aqueous solution (Miller et. al., 2012).
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Miller’s channels are not as small as Lewis’ channels. His channels range from 150 microns to around a millimeter in diameter.
However, when he and colleagues seeded the channels with
endothelial cells, they lined the interiors of the channels and
even began to penetrate the surrounding cell-gel mixture. By
guiding blood cells into the larger channels, he can set the stage
for endothelial cells to spontaneously form their own capillary
networks. Miller has successfully pumped human blood through
his constructs in vitro, and the research team plans to cooperate with a surgeon to connect one of his printed tissues to the
vascular system of a rat to see how long he can get blood to
flow through his channels (Miller et. al., 2012).
Vascularization procedures done by Miller and team take a
short amount of time to complete which benefits the large
scale tissues, like liver cells. Large scale tissue cannot survive
the several hours it takes in the extruder nozzle long enough to
build something the size of the human liver. Additionally, quickly
pouring the cells and gels over the 3-D–printed lattice is easier
on fragile cells than the arduous process of printing. The one
disadvantage is that the researchers cannot control the exact
placement of the cells. Therefore, this may not be the optimal
method for experiments involving multiple cell types. In the
versions of the constructs printed with rat liver cells or with
human embryonic kidney cells, the cells near the channels survive longer than the cells deeper in the gel, suggesting that the
experiment is leading in the right direction (Miller et. al., 2012).

Conclusion
At this present time, a 3D printed organ is unable to be inserted
into a patient with the same efficacy as a normal organ. Many more
years of research need to be conducted. There are constantly
many advances being made by countless numbers of research
teams who are devoted to help suffering patients and increase
the availability of organs for transplant. However, even though 3D
printed organs cannot be inserted into patients, they can be used
to assist doctors and surgeons in surgery. Advanced models of
organs that are 3D printed are able to prepare surgeons on what
they might encounter in the operating room. Simply by looking
at models, doctors are able to avoid potential complications that
could have been unforeseeable without the physical model. 3D
printed organs can also help train medical students and professionals. Researchers and Doctors are able to replicate the part of
the patient with the complicated problem so students can learn
how to go about saving lives. It also allows healthcare professionals to better explain situations to the patient. The healthcare
provider can physically hold the model and explain what is wrong
and the different procedures available for the patient. Currently,
the main use of the 3D printed organs has been for screening
new medications and modeling various diseases.
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